DK1380302T3 - Medikamenter mod retina- og choroidea-sygdomme indeholdende ste-roider som aktiv bestanddel - Google Patents

Medikamenter mod retina- og choroidea-sygdomme indeholdende ste-roider som aktiv bestanddel

Info

Publication number
DK1380302T3
DK1380302T3 DK02708676T DK02708676T DK1380302T3 DK 1380302 T3 DK1380302 T3 DK 1380302T3 DK 02708676 T DK02708676 T DK 02708676T DK 02708676 T DK02708676 T DK 02708676T DK 1380302 T3 DK1380302 T3 DK 1380302T3
Authority
DK
Denmark
Prior art keywords
active ingredient
retinal
medicines
diseases containing
containing steroids
Prior art date
Application number
DK02708676T
Other languages
English (en)
Inventor
Yasuo Tano
Tatsuji Kurose
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DK1380302T3 publication Critical patent/DK1380302T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DK02708676T 2001-03-28 2002-03-27 Medikamenter mod retina- og choroidea-sygdomme indeholdende ste-roider som aktiv bestanddel DK1380302T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001092329 2001-03-28
PCT/JP2002/002950 WO2002078713A1 (fr) 2001-03-28 2002-03-27 Medicaments contre les affections retiniennes et choroidiennes contenant des steroides comme principe actif

Publications (1)

Publication Number Publication Date
DK1380302T3 true DK1380302T3 (da) 2008-12-08

Family

ID=18946808

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02708676T DK1380302T3 (da) 2001-03-28 2002-03-27 Medikamenter mod retina- og choroidea-sygdomme indeholdende ste-roider som aktiv bestanddel

Country Status (12)

Country Link
US (1) US20040097478A1 (da)
EP (1) EP1380302B1 (da)
KR (1) KR100854058B1 (da)
CN (1) CN100353947C (da)
AT (1) ATE405274T1 (da)
CA (1) CA2442296C (da)
CY (1) CY1108572T1 (da)
DE (1) DE60228431D1 (da)
DK (1) DK1380302T3 (da)
ES (1) ES2311592T3 (da)
PT (1) PT1380302E (da)
WO (1) WO2002078713A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1666025A4 (en) * 2003-08-20 2011-08-31 Santen Pharmaceutical Co Ltd DRUG DELIVERY SYSTEM FOR THE SUBTENOIN DELIVERY OF FINE GRAINS
US7374219B2 (en) * 2004-09-22 2008-05-20 Zephyros, Inc. Structural reinforcement member and method of use therefor
RU2696045C1 (ru) * 2018-10-15 2019-07-30 Государственное бюджетное учреждение здравоохранения Московской области "Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского" (ГБУЗ МО МОНИКИ им. М.Ф. Владимирского) Способ лечения болезни Илза
IT201900014052A1 (it) * 2019-08-05 2021-02-05 Lucia Scorolli Preparazione para-bulbare con effetto citotrofico-retinico

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4454151A (en) * 1982-03-22 1984-06-12 Syntex (U.S.A.) Inc. Use of pyrrolo pyrroles in treatment of ophthalmic diseases
JPS61106521A (ja) * 1984-10-31 1986-05-24 Kureha Chem Ind Co Ltd 血管増殖抑制剤
DE69032012T2 (de) * 1989-08-28 1998-05-14 Alcon Lab Inc Ophthalmische zubereitung
US5104787A (en) 1990-03-05 1992-04-14 Lindstrom Richard L Method for apparatus for a defined serumfree medical solution useful for corneal preservation
KR0185215B1 (ko) * 1990-11-30 1999-05-01 요시다 쇼오지 서방성 안구삽입용 약제
EP1236471A3 (en) * 1991-11-22 2004-12-15 Alcon Laboratories, Inc. Angiostatic steroids
WO1993012808A1 (en) * 1991-12-20 1993-07-08 Shuji Nakamura A method for treating kaposi's sarcoma and blocking or inhibiting vascular permeability
US5770589A (en) * 1993-07-27 1998-06-23 The University Of Sydney Treatment of macular degeneration
TW420611B (en) * 1995-03-10 2001-02-01 R Tech Ueno Ltd Pharmaceutical composition containing prostanoic acid compounds for the treatment of optic nerve disorder
EP0847277A1 (en) * 1995-08-07 1998-06-17 Schering Corporation Treatment of ocular inflammatory conditions with interleukin-10
DE69738935D1 (de) * 1996-11-05 2008-10-02 Childrens Medical Center Zusammensetzungen enthaltend Thalidomide und Dexamethason für die Behandlung von Krebs
US5811446A (en) * 1997-04-18 1998-09-22 Cytos Pharmaceuticals Llc Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor
US6217895B1 (en) * 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
US6395294B1 (en) * 2000-01-13 2002-05-28 Gholam A. Peyman Method of visualization of the vitreous during vitrectomy
US6726918B1 (en) * 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye

Also Published As

Publication number Publication date
US20040097478A1 (en) 2004-05-20
EP1380302B1 (en) 2008-08-20
CA2442296C (en) 2010-06-22
CA2442296A1 (en) 2002-10-10
KR20030087029A (ko) 2003-11-12
EP1380302A1 (en) 2004-01-14
ES2311592T3 (es) 2009-02-16
DE60228431D1 (de) 2008-10-02
ATE405274T1 (de) 2008-09-15
CN1551775A (zh) 2004-12-01
CN100353947C (zh) 2007-12-12
CY1108572T1 (el) 2014-04-09
KR100854058B1 (ko) 2008-08-26
EP1380302A4 (en) 2006-04-12
WO2002078713A1 (fr) 2002-10-10
PT1380302E (pt) 2008-11-25

Similar Documents

Publication Publication Date Title
US4466973A (en) Method of treating nasal and sinus congestion
HRP20050781B1 (hr) Metode i farmaceutske mješavine za pouzdano postizanje prihvatljivih razina testosterona u serumu
US20060228306A1 (en) Combination antihistamine and steroid medication
NO20060200L (no) Farmasoytisk formulering for prevensjons- og hormonerstatningsterapier
DE69930252D1 (de) Verwendung von tetracyclinen zur behandlung von störungen der meibomschen drüsen
CA2502437A1 (en) Method and composition containing latanoprost for treating ocular hypertension and glaucoma
WO2004105694A3 (en) Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
NO954925D0 (no) Metode for behandling av smerte ved administrering av 24 timers orale opioidformuleringer som utviser hurtig stigningsgrad av plasmalegemiddelnivå
DE60334692D1 (de) Ophthalmologische zubereitung enthaltend roflumilast in der behandlung von krankheiten der augen
BRPI0409381A (pt) formulações farmacêuticas nasais e métodos de utilizar as mesmas
HUP9904362A2 (hu) Eljárás felső légúti allergiás tünetek kezelésére hisztamin H1 és H3 receptor-antagonisták kombinációjával
NO925038L (no) Anordning for nedsettelse av medikamentets hudirriterendevirkninger
JPH0269413A (ja) アレルギー性鼻炎の治療方法
IL156798A0 (en) Use of flumazenil in developing a drug for the treatment of alcohol dependency
BRPI0409434A (pt) formulações farmacêuticas nasais e métodos para usar as mesmas
DK1380302T3 (da) Medikamenter mod retina- og choroidea-sygdomme indeholdende ste-roider som aktiv bestanddel
SE9803761D0 (sv) Method to avoid increased iridial pigmentation during prostaglandin treatment
YU6196A (sh) Transdermalna flasterska formulacija
HUP0302036A2 (hu) Glükokortikoidot tartalmazó készítmény bronchopulmonális betegségek kezelésére
DK1343472T3 (da) Thixotropisk næsespray
TWI713618B (zh) 外用劑
DK1492539T3 (da) Statin-terapi til forögelse af kognitiv funktion
JPH0474135A (ja) 点眼組成物
EP4151210A3 (en) Pyridine-carboline derivatives as mchr1 antagonists for use in therapy
DK0654267T3 (da) Carcinostatisk middel til hormonterapi indeholdende dienogest som aktiv komponent